121 related articles for article (PubMed ID: 38340319)
1. GLUT1-mediated glucose import in B cells is critical for anaplerotic balance and humoral immunity.
Bierling TEH; Gumann A; Ottmann SR; Schulz SR; Weckwerth L; Thomas J; Gessner A; Wichert M; Kuwert F; Rost F; Hauke M; Freudenreich T; Mielenz D; Jäck HM; Pracht K
Cell Rep; 2024 Feb; 43(2):113739. PubMed ID: 38340319
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial respiration in B lymphocytes is essential for humoral immunity by controlling the flux of the TCA cycle.
Urbanczyk S; Baris OR; Hofmann J; Taudte RV; Guegen N; Golombek F; Castiglione K; Meng X; Bozec A; Thomas J; Weckwerth L; Mougiakakos D; Schulz SR; Schuh W; Schlötzer-Schrehardt U; Steinmetz TD; Brodesser S; Wiesner RJ; Mielenz D
Cell Rep; 2022 Jun; 39(10):110912. PubMed ID: 35675769
[TBL] [Abstract][Full Text] [Related]
3. Glucose transporter 1-mediated glucose uptake is limiting for B-cell acute lymphoblastic leukemia anabolic metabolism and resistance to apoptosis.
Liu T; Kishton RJ; Macintyre AN; Gerriets VA; Xiang H; Liu X; Abel ED; Rizzieri D; Locasale JW; Rathmell JC
Cell Death Dis; 2014 Oct; 5(10):e1470. PubMed ID: 25321477
[TBL] [Abstract][Full Text] [Related]
4. Glucose transporter 1 in rheumatoid arthritis and autoimmunity.
Zezina E; Sercan-Alp O; Herrmann M; Biesemann N
Wiley Interdiscip Rev Syst Biol Med; 2020 Jul; 12(4):e1483. PubMed ID: 32084302
[TBL] [Abstract][Full Text] [Related]
5. Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells.
Caro-Maldonado A; Wang R; Nichols AG; Kuraoka M; Milasta S; Sun LD; Gavin AL; Abel ED; Kelsoe G; Green DR; Rathmell JC
J Immunol; 2014 Apr; 192(8):3626-36. PubMed ID: 24616478
[TBL] [Abstract][Full Text] [Related]
6. Role of the GLUT1 Glucose Transporter in Postnatal CNS Angiogenesis and Blood-Brain Barrier Integrity.
Veys K; Fan Z; Ghobrial M; Bouché A; García-Caballero M; Vriens K; Conchinha NV; Seuwen A; Schlegel F; Gorski T; Crabbé M; Gilardoni P; Ardicoglu R; Schaffenrath J; Casteels C; De Smet G; Smolders I; Van Laere K; Abel ED; Fendt SM; Schroeter A; Kalucka J; Cantelmo AR; Wälchli T; Keller A; Carmeliet P; De Bock K
Circ Res; 2020 Jul; 127(4):466-482. PubMed ID: 32404031
[TBL] [Abstract][Full Text] [Related]
7. mTORC1-GLUT1-mediated glucose metabolism drives hyperactivation of B cells in primary Sjogren's syndrome.
Luo X; Wu X; Wang A; Chen Y; Peng Y; Deng C; Zhao L; Yang H; Zhou J; Peng L; Wu Q; Li M; Zhao Y; Zeng X; Zhang W; Fei Y
Immunology; 2023 Mar; 168(3):432-443. PubMed ID: 36155926
[TBL] [Abstract][Full Text] [Related]
8. Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype.
Freemerman AJ; Johnson AR; Sacks GN; Milner JJ; Kirk EL; Troester MA; Macintyre AN; Goraksha-Hicks P; Rathmell JC; Makowski L
J Biol Chem; 2014 Mar; 289(11):7884-96. PubMed ID: 24492615
[TBL] [Abstract][Full Text] [Related]
9. The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function.
Macintyre AN; Gerriets VA; Nichols AG; Michalek RD; Rudolph MC; Deoliveira D; Anderson SM; Abel ED; Chen BJ; Hale LP; Rathmell JC
Cell Metab; 2014 Jul; 20(1):61-72. PubMed ID: 24930970
[TBL] [Abstract][Full Text] [Related]
10. Propofol regulates activated macrophages metabolism through inhibition of ROS-mediated GLUT1 expression.
Zeng W; Xing Z; Tan M; Wu Y; Zhang C
Inflamm Res; 2021 Apr; 70(4):473-481. PubMed ID: 33751130
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta-1 upregulates glucose transporter 1 and glycolysis through canonical and noncanonical pathways in hepatic stellate cells.
Zhou MY; Cheng ML; Huang T; Hu RH; Zou GL; Li H; Zhang BF; Zhu JJ; Liu YM; Liu Y; Zhao XK
World J Gastroenterol; 2021 Oct; 27(40):6908-6926. PubMed ID: 34790014
[TBL] [Abstract][Full Text] [Related]
12. Protective Humoral Immunity in the Central Nervous System Requires Peripheral CD19-Dependent Germinal Center Formation following Coronavirus Encephalomyelitis.
Atkinson JR; Bergmann CC
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931676
[TBL] [Abstract][Full Text] [Related]
13. TAPP Adaptors Control B Cell Metabolism by Modulating the Phosphatidylinositol 3-Kinase Signaling Pathway: A Novel Regulatory Circuit Preventing Autoimmunity.
Jayachandran N; Mejia EM; Sheikholeslami K; Sher AA; Hou S; Hatch GM; Marshall AJ
J Immunol; 2018 Jul; 201(2):406-416. PubMed ID: 29884706
[TBL] [Abstract][Full Text] [Related]
14. Suppression of Glut1 and Glucose Metabolism by Decreased Akt/mTORC1 Signaling Drives T Cell Impairment in B Cell Leukemia.
Siska PJ; van der Windt GJ; Kishton RJ; Cohen S; Eisner W; MacIver NJ; Kater AP; Weinberg JB; Rathmell JC
J Immunol; 2016 Sep; 197(6):2532-40. PubMed ID: 27511728
[TBL] [Abstract][Full Text] [Related]
15. Myeloid
Freemerman AJ; Zhao L; Pingili AK; Teng B; Cozzo AJ; Fuller AM; Johnson AR; Milner JJ; Lim MF; Galanko JA; Beck MA; Bear JE; Rotty JD; Bezavada L; Smallwood HS; Puchowicz MA; Liu J; Locasale JW; Lee DP; Bennett BJ; Abel ED; Rathmell JC; Makowski L
J Immunol; 2019 Feb; 202(4):1265-1286. PubMed ID: 30659108
[TBL] [Abstract][Full Text] [Related]
16. Disruption of Glut1 in Hematopoietic Stem Cells Prevents Myelopoiesis and Enhanced Glucose Flux in Atheromatous Plaques of ApoE(-/-) Mice.
Sarrazy V; Viaud M; Westerterp M; Ivanov S; Giorgetti-Peraldi S; Guinamard R; Gautier EL; Thorp EB; De Vivo DC; Yvan-Charvet L
Circ Res; 2016 Apr; 118(7):1062-77. PubMed ID: 26926469
[TBL] [Abstract][Full Text] [Related]
17. Unique mechanism of GLUT3 glucose transporter regulation by prolonged energy demand: increased protein half-life.
Khayat ZA; McCall AL; Klip A
Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):713-8. PubMed ID: 9677332
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylcholine as a metabolic cue for determining B cell fate and function.
Brewer JW; Solodushko V; Aragon I; Barrington RA
Cell Immunol; 2016 Dec; 310():78-88. PubMed ID: 27502364
[TBL] [Abstract][Full Text] [Related]
19. Human Plasmablast Migration Toward CXCL12 Requires Glucose Oxidation by Enhanced Pyruvate Dehydrogenase Activity
Pak HK; Nam B; Lee YK; Kim YW; Roh J; Son J; Chung YS; Choe J; Park CS
Front Immunol; 2018; 9():1742. PubMed ID: 30100910
[TBL] [Abstract][Full Text] [Related]
20. A small-molecule pan-class I glucose transporter inhibitor reduces cancer cell proliferation in vitro and tumor growth in vivo by targeting glucose-based metabolism.
Shriwas P; Roberts D; Li Y; Wang L; Qian Y; Bergmeier S; Hines J; Adhicary S; Nielsen C; Chen X
Cancer Metab; 2021 Mar; 9(1):14. PubMed ID: 33771231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
